Optimising the analysis of vascular prevention trials: Re-Assessment of the TARDIS trial, the first prevention trial to adopt an ordinal primary outcome measure.

Woodhouse, Lisa J; Montgomery, Alan A; Pocock, Stuart; James, Marilyn; Ranta, Anna; Bath, Philip M

Woodhouse, Lisa J; Montgomery, Alan A; Pocock, Stuart; James, Marilyn; Ranta, Anna; Bath, Philip M.

Afiliação

Woodhouse LJ; Stroke Trials Unit, Mental Health & Clinical Neurosciences, School of Medicine, University of Nottingham, D Floor South Block, Queen's Medical Centre, Nottingham, NG7 2UH, UK.
Montgomery AA; Nottingham Clinical Trials Unit, University of Nottingham, Queen's Medical Centre, Derby Road, Nottingham, NG7 2UH, UK.
Pocock S; London School of Hygiene & Tropical Medicine, Keppel St., London, WC1E 7HT, UK.
James M; Nottingham Clinical Trials Unit, University of Nottingham, Queen's Medical Centre, Derby Road, Nottingham, NG7 2UH, UK.
Ranta A; Department of Medicine, University of Otago Wellington, Wellington, 6242, New Zealand.
Bath PM; Stroke Trials Unit, Mental Health & Clinical Neurosciences, School of Medicine, University of Nottingham, D Floor South Block, Queen's Medical Centre, Nottingham, NG7 2UH, UK.

Contemp Clin Trials Commun ; 35: 101186, 2023 Oct.

Article em En | MEDLINE | ID: mdl-37745289

Palavras-chave

Outcome; Severity; Stroke; TARDIS; Time

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Guideline Idioma: En Revista: Contemp Clin Trials Commun Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google